• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 25 Apr

    Quoin Pharmaceuticals Announces FDA Clearance of IND for its Lead Asset, QRX003, for Netherton Syndrome

    Quoin Will Initiate Clinical Testing in 1H 2022 ASHBURN, Va., April 25, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced that it has received U.S. Food and Drug Administration (FDA) clearance to initiate… Read More..

    Share this:
  • 22 Apr

    Aclarion, Inc. Announces Listing on Nasdaq and Pricing of $9.4 Million Initial Public Offering

    SAN MATEO, CA / ACCESSWIRE / April 21, 2022 / Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ:ACON)(NASDAQ:ACONW), a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), artificial intelligence and a proprietary biomarker to optimize clinical treatments for low back and neck pain, today announced the pricing of its initial public… Read More..

    Share this:
  • 21 Apr

    Multiband Global to Showcase Clean Energy Solutions at 2022 Byron Nelson Tournament

    Company’s Helios Energy Solutions will be showcased at prestigious event AUSTIN, TX , April 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Metals Recovery and Recycling, Inc. (“AMRR”) (OTC Pink: AMRR), holding company of Multiband Global (MBG), a leading IT and network lifecycle company, will showcase MBG’s Helios clean energy solutions at the… Read More..

    Share this:
« Previous 1 … 28 29 30 31 32 … 295 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact